(Q36494145)

14 August 2017

1 reference

title

Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction (English)

1 reference

14 August 2017

Dunn ME

1

1 reference

14 August 2017

Althof SE

series ordinal

2

1 reference

14 August 2017

Perelman MA

series ordinal

3

1 reference

14 August 2017

publication date

1 June 2006

1 reference

International Journal of Impotence Research

14 August 2017

published in

1 reference

14 August 2017

volume

19

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

119-123

1 reference

The role of the partner in erectile dysfunction and its treatment

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Summary of the recommendations on sexual dysfunctions in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

The psychological and interpersonal relationship scales: assessing psychological and relationship outcomes associated with erectile dysfunction and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Quality of life and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

When an erection alone is not enough: biopsychosocial obstacles to lovemaking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Psychotherapy for erectile dysfunction: now more relevant than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Sex coaching for physicians: combination treatment for patient and partner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Onset and duration of action of sildenafil for the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Efficacy of sildenafil citrate at 12 hours after dosing: re-exploring the therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Therapy of ED: PDE-5 Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Psychosocial evaluation and combination treatment of men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Comparison between sildenafil-treated subjects with erectile dysfunction and control subjects on the Self-Esteem And Relationship questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Perceptions of well-being in sexual ill health: what role does age play?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

The 'effectiveness' scale--therapeutic outcome of pharmacologic therapies for ED: an international consensus panel report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Psychological perspectives of sex and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Update on oral treatments for male erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Clinical evaluation and management strategy for sexual dysfunction in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

Physician-patient dialogue and clinical evaluation of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

inferred from DOI database lookup

7 January 2021

based on heuristic

Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901490

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.IJIR.3901490

1 reference

14 August 2017

1 reference